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Abstract
Background: Leishmania parasites have been reported to interfere and even subvert their host immune responses
to enhance their chances of survival and proliferation. Experimental Leishmania infection in mice has been widely
used in the identification of specific parasite virulence factors involved in the interaction with the host immune
system. Cysteine-proteinase B (CPB) is an important virulence factor in parasites from the Leishmania (Leishmania)
mexicana complex: it inhibits lymphocytes Th1 and/or promotes Th2 responses either through proteolytic activity
or through epitopes derived from its COOH-terminal extension. In the present study we analyzed the effects of
Leishmania (Leishmania) amazonensis CPB COOH-terminal extension-derived peptides on cell cultures from murine
strains with distinct levels of susceptibility to infection: BALB/c, highly susceptible, and CBA, mildly resistant.
Results: Predicted epitopes, obtained by in silico mapping, displayed the ability to induce cell proliferation and
expression of cytokines related to Th1 and Th2 responses. Furthermore, we applied in silico simulations to
investigate how the MHC/epitopes interactions could be related to the immunomodulatory effects on cytokines,
finding evidence that specific interaction patterns can be related to in vitro activities.
Conclusions: Based on our results, we consider that some peptides from the CPB COOH-terminal extension may
influence host immune responses in the murine infection, thus helping Leishmania survival.
Background
Leishmaniasis, a vector-borne parasitic infection, is
caused by protozoans of the genus Leishmania,w h i c h
present a worldwide distribution. This disease is charac-
terized by its diversity and complexity, presenting a wide
spectrum of clinical forms in humans, ranging from self-
healing skin lesions to fatal visceral leishmaniasis,
depending on parasite species and host factors [1,2].
In Brazil, both clinical forms are present and, currently,
leishmaniasis can be classified as a disease in expansion
and without effective control [3]. One important etiologi-
cal agent of human leishmaniasis in Brazil is Leishmania
(Leishmania) amazonensis, which causes a wide spectrum
of clinical diseases [4]. Interestingly, recent findings indi-
cate that the geographical distribution of L. (L.) amazo-
nensis is increasing, accounting for unusual clinical
presentations in new transmission areas, specifically Rio
de Janeiro State [5].
Amastigote forms of Leishmania are intracellular para-
sites, inhabiting preferentially cells of the mononuclear
phagocyte system, and present a series of adaptive peculia-
rities in this phase of the biological cycle. These adapta-
tions allow the parasites to escape or interfere with the
host immune responses and, consequently, maintain the
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any medium, provided the original work is properly cited.infection. The host immunological profiles during Leish-
mania infections are widely studied using the murine
model, as distinct leishmaniasis clinical manifestations can
be reproduced in inbred mice strains [reviewed in [6]].
In the murine Leishmania (Leishmania) major infec-
tion model it has been established that a T-helper cell
type 1 (Th1) immune response is effective against the
parasites, while a Th2 response may lead to disease
exacerbation. Thus, in this system, the outcome of infec-
tion is determined by the balance between these two
types of response [7]. However, this dichotomy is not so
clearly observed in murine infections caused by the Leish-
mania (Leishmania) mexicana complex species, as L. (L.)
amazonensis, where the susceptibility of the host to the
infection seems to be associated with an insufficient Th1
response rather than a dominant Th2 response [8]. The
distinct levels of susceptibility to infection observed in
different mouse strains, e.g. BALB/c mice being highly
susceptible and CBA mice having some degree of resis-
tance, may be due to differences in a mixed Th responses
balance rather than determined by a single dominant
response. Additionally, regulatory cytokines, as IL-10,
might influence the outcome of the infection in a manner
not directly linked to the Th1/Th2 dichotomy [9].
In this context, cysteine proteinases (CPs) (E.C. 3.4.22)
are virulence factors for Leishmania with immunoregu-
latory properties during infection [10]. Most of the stu-
dies on Leishmania CPs are centered in a few enzymes,
denominated CPA, CPB and CPC, all of which are simi-
lar to papain and belong to the same group of CPs
(designated Clan CA, Family C1). However, a detailed
analysis of the L. (L.) major genome database revealed
the existence of genes predicted to codify for a total of
56 CPs, subdivided into 4 Clans and 13 Families [10].
T h ec u r r e n tf o c u so fo u rs t u d i e si sC P B ,ac a t h e p s i n
L-like enzyme [11], which presents exclusive characteris-
tics when compared to other CPs: an extension of
approximately 100 aa in its COOH-terminal region and
the presence of multicopies organized as tandem array
i nt h ep a r a s i t eg e n o m e[ 1 0 ] .C P Bf r o mL. (L.) mexicana
and L. (L.) amazonensis have been shown to have a role
on the Th1/Th2 responses balance by cleaving type II
major histocompatibility complex (MHC) molecules in
the host parasitophorous vacuole [12], cleaving the
interleukin (IL)-2 and immunoglobulin (Ig) E receptors,
inducing IL-4 expression [13], inhibiting IL-12 produc-
tion in macrophages and dentritic cells [14] and by
cleaving host nuclear factor kappa B (NF-B) [15]. Con-
sidering that during the processing of pre-CPB to its
mature form the COOH-terminal extension is processed
[16], secreted [17] and can be observed within host cells
[18], this released fragment may also play a role in the
host-parasite interaction [19].
Our group previously published an in silico study,
using the analysis of physicochemical characteristics as
parameter for T cell epitopes prediction, that allowed
the identification of three peptides from L. (L.) mexicana
CPB COOH-terminal extension. In that study, three
peptides with electric charges, hydrophobicity and iso-
electric points compatible with the binding to MHC
molecules were selected [20].
These peptides were chemically synthesized and used
in vivo and in vitro studies using BALB/c and CBA
mice. One of these peptides caused an exacerbating
effect on BALB/c mice lesions, when used in vaccination
assays. Moreover, lymphoproliferative assays indicated
that CD8
+ T cells proliferated more intensely than CD4
+ Tc e l l si nt h ep r e s e n c eo ft h a ts a m ep e p t i d e .W h e n
cytokine levels were assessed, interferon-g (IFN-g), a
Th1 response-related cytokine, was detected only in the
supernatant of CBA lymph node cell culture, while IL-4,
a Th2 response-related cytokine, was detected in the
supernatant of cell culture from both lineages. Addition-
ally, nitric oxide (NO) was detected only in the superna-
tant of CBA cell cultures [21].
Such data corroborated the potential of CPB as an indu-
cer of a Th2 immune response, showing that peptides
derived from this enzyme may be influential co-stimula-
tory signals in T-cell polarization during leishmaniasis,
able to interfere in the balance of the Th immune
responses.
In the present study, we searched further for immuno-
modulatory peptides derived from the COOH-terminal
extension of L. (L.) amazonensis CPB. This was achieved
by using current online algorithms to directly define
peptides able to bind to MHC molecules and by using
in vitro assays to assess the effect of the various peptides
on mouse strains with distinct levels of susceptibility to
L. (L.) amazonensis infection.
Results
Sequencing of the L. (L.) amazonensis CPB COOH-terminal
extension
L. (L.) amazonensis CPB COOH-terminal extension
encoding genome sequence was amplified and cloned
using primers previously produced for an analogous
region of L. (L.) pifanoi CPB. After determination of
the DNA sequence, it was used as basis for deducing
amino acids sequence of the COOH-terminal exten-
sion (Figure 1).
This sequence presented up to 93% of identity with
sequences of CPs from other Leishmania species
belonging to the L. (L.) mexicana complex and up to
68% with species from other complexes, as indicated by
a protein BLAST analysis using the compositional
matrix adjust method.
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COOH-terminal extension of L. (L.) amazonensis CPB
The deduced amino acids sequence for the COOH-term-
inal extension of L. (L.) amazonensis CPB was analyzed
by online algorithms to predict proteasome cleavage
(NetChop and PAProC) and MHC-binding peptides
(SYFPEITHI). Only peptides commonly predicted by the
three algorithms used were considered for this study
(Table 1). These predicted epitopes were then synthe-
sized for in vitro analyses. All synthetic peptides were
tested for endotoxin presence and presented values
below the assay threshold (data not shown).
Each synthetic peptide was assayed only with the mouse
strain that presented the haplotype to which it showed
binding properties in SYFPEITHI analysis. Thus, P1, P4,
P5, P6 and P7 were assayed only with BALB/c mice, P3
and P9 were assayed only with CBA mice, while P2 and
P8 were assayed with both mice strains.
T lymphocytes proliferative responses induced by
synthetic peptides
Assays carried out with BALB/c cells showed that pep-
tides P4 and P5 were able to induce a low level of cell
proliferation when co-incubated with lymph node cells
(2.2-fold and 1.7-fold increase in cell number, respec-
tively) (Figure 2A). As for CBA mice cells, peptides P2,
P8 and P9 also showed activity (2-fold, 1.7-fold and 2.3-
fold increase in cell number, respectively) (Figure 2B).
Positive blastogenesis control with Con A showed a
7.2-fold and 6.2-fold increase in cell numbers for BALB/
c and CBA cell cultures, respectively. Specific blasto-
genic response control with Particulate Leishmania anti-
gen (PLA) also showed a slight proliferation (1.9-fold
and 1.4-fold increase in cell number for BALB/c and
CBA, respectively).
Influence of the predicted epitopes on lymph node cells
phenotype
BALB/c lymph node cell cultures incubated with pep-
tides P5 and P6 showed a decrease in the percentage of
CD8
+ T cells (31% and 17% decrease when compared to
control cultures, respectively). In contrast, peptide P8
was able to increase the percentage of BALB/c CD8
+
T cells present in the cultures by 34% (Figure 3A). As
for the percentage of CD4+ T cells in the cultures, P8
was able to reduce the number of this cell type in the
BALB/c lymph node cells by 65% (Figure 3D). None of
the tested peptides was able to significantly alter CD8
+
or CD4
+ percentages in lymph node cell cultures from
CBA mice.
P8 showed a strong influence over both CD4
+ and
CD8
+ in BALB/c cells, being able to alter the propor-
tions between these two cell types in the culture. While
the CD8+:CD4+ proportion in control cultures was of
0.5, P8-incubated cultures presented a proportion of 1.8.
Peptides P5 and P6 also altered the proportion between
these two cell types, but as they influenced only CD8
+
cell numbers these alterations were less significant,
5’- gcacccagacccgtgatggtggagcaggtgatctgcttcgataagaactgcactcaggggtgcaagaaaaccctgatcaaggcgaacgagtgc
Nt- A  P  R  P  V  M  V  E  Q  V  I  V  F  D  K  N  C  T  Q  G  C  K  K  T  L  I  K  A  N  E  C  
cacaagaacgggggaggaggcgcctctatgatcaagtgcagtccgcagacggtgacgatgtgcacgtactcgaacgaattctgcctgggcgggggg
H  K  N  G  G  G  G  A  S  M  I  K  C  S  P  Q  T  V  T  M  C  T  Y  S  N  E  F  C  L  G  G  G   
ctgtgcctcgagactcctgatggtaagtgcgcgccgtactttttgggctcggtcattaacacctgtcactacacg -3’
L  C  L  E  T  P  D  G  K C  A  P  Y  F  L  G  S  V  I  N  T  C  H  Y  T   -Ct 
Figure 1 Nucleotide (above) and amino acid (below) sequences of the COOH-terminal extension from L. (L.) amazonensis CPB.
Sequences are informed as 5’ ® 3’ and NH3-terminal (Nt) ® COOH-terminal (Ct), respectively.
Table 1 Putative T lymphocytes epitopes from the COOH-terminal extension from L. (L.) amazonensis CPB
Epitope Amino acids sequence Number of
amino acids
Binds to H-2
haplotype (predicted)
SYFPEITHI score value
P1 KNGGGGASMI 10 D 13
P2 NGGGGASMI 9 d and k 15/13
P3 GGGGASMI 8 K 13
P4 MCTYSNEFCL 10 D 10
P5 CTYSNEFCL 9 D 12
P6 FCLGGGLCL 9 D 17
P7 CAPYFLGSVI 10 D 11
P8 APYFLGSVI 9 d and k 13/13
P9 PYFLGSVI 8 K 13
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Page 3 of 12establishing a CD8
+:CD4
+ proportion of 0.3, after incu-
bation with peptides.
Blastogenesis positive control (incubated with Con A)
did not present any variations on CD8
+:CD4
+ propor-
tions, while cultures with PLA showed results compar-
able to what was observed for P8: CD8
+ cells percentage
increased by 115%, CD4
+ cells percentage decreased by
75% and CD8
+:CD4
+ proportion of 3.5.
Production of cytokines and nitric oxide by cells in
culture incubated with predicted epitopes
The levels of expression of cytokines related to Th1 and
Th2 responses were analyzed in the supernatants of lymph
node cell cultures co-incubated with the synthetic pep-
tides. Also, the levels of IL-10 expression, a cytokine
currently known to act in regulation of immune responses,
were tested. In parallel, the NO levels in these superna-
tants were also analyzed. The basic values of all the assays
(the mean values obtained for negative control cell cul-
tures) were subtracted from the values obtained from all
the samples and positive controls. The cytokine profiles in
these cell cultures can be related to the capacity of the
infected mice to control Leishmania infection, thus these
parameters were analyzed in cell cultures from BALB/c
(Table 2) and CBA (Table 3) mice. One Th2-related cyto-
kine (IL-4), two Th1-related cytokines (IL-12 and IFN-g)
and one regulatory cytokine (IL-10) were tested.
In BALB/c cell cultures, peptides P1 and P2 promoted
the expression of Th1-related cytokines (IL-12 and IFN-
g, respectively), while P6 promoted the expression of
IL-10. The peptide P4 was able to induce cytokines
from distinct Th responses in these cell cultures (IL-10
and IFN-g). Con A and PLA controls were able to
induce the expression of all tested cytokines.
Assays with CBA cells evidenced the capacity of pep-
tides P2 and P3 to induce the expression of a Th1-
related cytokine (IL-12), whereas peptides P8 induced
t h ee x p r e s s i o no far e g u l a t o r yc y t o k i n e( I L - 1 0 ) .A s
observed in BALB/c cell cultures, one of the tested pep-
tides (P9) was able to promote the expression of cyto-
kines from multiple Th responses (IL-10 and IL-12). In
CBA cell cultures, Con A displayed an activity similar to
the pattern observed with BALB/c cells, but PLA was
unable to promote IL-12 expression, although inducing
the expression of all other tested cytokines.
None of the tested peptides was able to induce NO
production in cell cultures from the tested murine
strains, although, in BALB/c cultures, Con A and PLA
enhanced NO levels in supernatants. In CBA cell cul-
tures, only PLA enhanced NO levels in the supernatant.
H-2/peptides complexes interactions predicted by
molecular docking assays
The number of hydrogen bonds and Van der Waals con-
tacts, along with the intermolecular energies of the com-
plexes were calculated using virtual models by molecular
docking assays (Figures 4, 5 and 6). Such data are impor-
tant to verify if binding of peptides to H-2 cleft, accord-
ing to molecular docking analysis, is feasible.
Redocking assays of the peptides, originally present in
the cleft, were used as control. For H-2K
k/1zt7 complex,
redocking assays presented 18% of success rate (consid-
ering an acceptable RMSD variation of up to 1.5%),
while H-2K
d/1vgk assays presented 100% of success
under the same parameter. The significantly lower suc-
cess rate observed for H-2K
k/1zt7 complex redocking
can be related to the higher number of side chain dihe-
dral angles of the ligand (28 points of torsion), whereas
peptide 1vgk presents 17 points of torsion. Despite the
apparent low redocking success rate for H-2K
k/1zt7
complex, the best model obtained by the in silico assays
presented an excellent match with the crystallized struc-
ture, thus proving adequate for the proposed analysis.
Molecular interaction data may also be helpful to
understand how the H-2 molecules and ligands interact,
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Figure 2 Blastogenesis of murine lymph node cells induced by
synthetic peptides derived from the COOH-terminal extension
of L. (L.) amazonensis CPB. Cell cultures from 15 infected BALB/c
(A) or CBA (B) mice were incubated for 3 days in 96-well plates with
synthetic peptides (30 μg/mL), PLA (30 μg/mL) or Con A (2 μg/mL),
coincubated with [
3H]-timidine (0.1 μCi/well) in the final 16 h of
culture and incorporated radioactivity (indicative of cell proliferation)
was measured in a beta-scintillation counter. Results are from a
representative assay from at least three independent repeats.
*Statistically distinct from control (p < 0.05).
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Page 4 of 12when a qualitative/quantitative analysis is applied rather
t h a nas i m p l yq u a n t i t a t i v eo n e ,a n dt h eo b s e r v e dm o l e -
cular interaction patterns can be related to the biological
effects caused by the peptides.
T h ed o c k i n ga s s a y sp r e d i c t e dt h a ts o m ea m i n oa c i d s
from the H-2 cleft present key importance in the interac-
tion of the MHC molecule with the epitope, evidenced
through their capacity of forming a high number of
hydrogen bonds and Van der Waals interactions. For the
haplotype d (H-2K
d) these apparently prevalent amino
acids were: Gln 63, Arg 66, Trp 73, Arg 97, Thr 143, Trp
147, Tyr 155 and Tyr 159. Also, some amino acids seem
to have importance only for Van der Waals interactions:
Phe 99, Tyr 156 and Trp 167. For the H-2K
k haplotype
(from CBA mice), the relevant amino acids for hydrogen
bonds and Van der Waals interactions were: Asn 70, Asn
77, Tyr 99, Tyr 116, Trp 147 and Asn 156, whereas those
in which Van der Waals interactions significantly
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Figure 3 Percentages of CD8+ (A and B) and CD4+ cells (C and D) in murine lymph node cell cultures after incubation with synthetic
peptides derived from the COOH-terminal extension of L. (L.) amazonensis CPB. Cell cultures from 15 infected BALB/c (A and C) or CBA (B
and D) mice were incubated for 3 days in 24-well plates with synthetic peptides (30 μg/mL), PLA (30 μg/mL) or Con A (2 μg/mL), stained with
specific CD4 and CD8 antibodies conjugated to fluorophores and submitted to analysis by flow cytometry. Results are from a representative
assay from at least three independent repeats. *Statistically distinct from control (p < 0.05).
Table 2 Cytokines levels in lymphnode cell cultures from infected BALB/c mice after coincubation with synthetic
peptides
pg/mL μM
IL-4 IL-10 IL-12 IFN-g NO
Con A 979.69 ± 3.79 590.30 ± 77.20 32.16 ± 5,21 872.33 ± 17.12 7.78 ± 3.49
PLA 37.82 ± 5.67 188.30 ± 34.88 12.02 ± 11,77 474.92 ± 92.24 0.84 ± 0.13
P1 ND ND 75.00 ± 34.65 ND ND
P2 ND ND ND 15.88 ± 3.19 ND
P4 ND 10.97 ± 2.47 ND 49.25 ± 20.10 ND
P5 ND ND ND ND ND
P6 ND 2.97 ± 0.82 ND ND ND
P7 ND ND ND ND ND
P8 ND ND ND ND ND
Results presented are from a representative assay from three independent repeats using lymph nodes from 15 infected mice. Results are presented as mean ±
standard deviation values. ND - below the threshold established by control group.
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Page 5 of 12contributed were: Tyr 7, Arg 97, Tyr 123, Arg 155 and
Tyr 159.
In addition, the participation of some residues from the
MHC cleft in the epitope binding was observed as
exclusively or predominantly occurring for peptides able
to induce the expression of a specific cytokine or a com-
bination of cytokines in the cell cultures. Interactions
were considered exclusive when formed only by peptides
capable to induce a specific cytokine, while predominant
Table 3 Cytokines levels in lymphnode cell cultures from infected CBA mice after coincubation with synthetic peptides
pg/mL μM
IL-4 IL-10 IL-12 IFN-g NO
Con A 226.84 ± 9.53 338.10 ± 11.49 26.85 ± 11.94 939.48 ± 0.00 ND
PLA 33.67 ± 4.82 68.57 ± 6,88 ND 87.06 ± 12,23 1.39 ± 0.96
P2 ND ND 18.37 ± 11.58 ND ND
P3 ND ND 16.44 ± 3.25 ND ND
P8 ND 27.46 ± 0.74 ND ND ND
P9 ND 21.03 ± 0.16 8.02 ± 3.85 ND ND
Results presented are from a representative assay from three independent repeats using lymph nodes from 15 infected mice. Results are presented as mean ±
standard deviation values. ND - below the threshold established by control group.
Ͳ45
Ͳ40
Ͳ35
Ͳ30
Ͳ25
Ͳ20
Ͳ15
Ͳ10
Ͳ5
0
1vgk P1 P2 P4 P5 P6 P7 P8
P
r
e
d
i
c
t
e
d

i
n
t
e
r
m
o
l
e
c
u
l
a
r

e
n
e
r
g
y

(
k
c
a
l
/
m
o
l
)
Ͳ45
Ͳ40
Ͳ35
Ͳ30
Ͳ25
Ͳ20
Ͳ15
Ͳ10
Ͳ5
0
1zt7 P2 P3 P8 P9
P
r
e
d
i
c
t
e
d

i
n
t
e
r
m
o
l
e
c
u
l
a
r

e
n
e
r
g
y

(
k
c
a
l
/
m
o
l
)
A
B
Figure 4 Predicted intermolecular energy (kcal/mol) of the
complexes H2/epitope by the in silico docking assays. Putative
epitopes P1, P2, P4, P5, P6, P7 and P8 were assayed with H-2K
d -
BALB/c mice (A), while P2, P3, P8 and P9 were assayed with H-2K
k -
CBA mice (B). Control assays were performed by redocking the
original cocrystallized epitopes to their respective H-2 haplotype
(PDB codes: 1vgk and 1zt7).
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Figure 5 Predicted number of van der Waals contacts of the
complexes H2/epitopes by the in silico docking assays. Putative
epitopes P1, P2, P4, P5, P6, P7 and P8 were assayed with H-2K
d -
BALB/c mice (A), while P2, P3, P8 and P9 were assayed with H-2K
k -
CBA mice (B). Control assays were performed by redocking the
original cocrystallized epitopes to their respective H-2 haplotype
(PDB codes: 1vgk and 1zt7).
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Page 6 of 12interactions were formed by peptides able to induce a
specific cytokine at least two times more frequently than
by other peptides (Table 4).
Discussion
Infection by Leishmania is a very complex process where
both the host immune system and parasite virulence com-
ponents interact and influence each other to respond in
specific ways, thus determining the outcome of the infec-
tion. Some L. (L.) amazonensis factors are able to directly
interfere with the host immune system and lead to a
response that benefits parasite survival [12].
In the present study, we have aimed at defining a strat-
egy that, combining in silico and in vitro assays, would
help to identify peptides from L. (L.) amazonensis that pre-
sent immunoregulatory properties. We based our present
analysis on putative epitopes derived from the COOH-
terminal extension from L. (L.) amazonensis CPB, as our
group had previously studied, by other methodologies, epi-
topes from this same region [20,21]. In our previous
reports, epitopes mapping was performed by analyzing
structural and chemical information of amino acids
sequences rather than by applying sequences to algorithms
designed for the simulation of epitopes processing and
MHC interaction.
We initially sequenced the COOH-terminal region from
L. (L.) amazonensis CPB. The sequence obtained, although
very similar to the sequence described for L. (L.) mexicana,
presented some differences in its deduced amino acid
sequence, thus indicating the possible existence of epi-
topes exclusive for L. (L.) amazonensis. These exclusive
epitopes may be related to some particularities of the
infection caused by this Leishmania species, perhaps con-
tributing to the stimulus of sub-populations of CD4
+
T cells related to pathogenesis [22].
A previous study reported the prediction of murine
MHC class I-binding epitopes from L. (L.) major proteins
using online algorithms. Differences in the number of
predicted epitopes between a susceptible and a resistant
mice strain were observed [23]. However, no in vitro ana-
lysis of the predicted epitopes was carried out and the
prediction strategy was focused on finding as many epi-
topes as possible, merging results from four algorithms.
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Figure 6 Predicted number of hydrogen bonds of the
complexes H-2/epitope by the in silico docking assays. Putative
epitopes P1, P2, P4, P5, P6, P7 and P8 were assayed with H-2K
d -
BALB/c mice (A), while P2, P3, P8 and P9 were assayed with H-2K
k -
CBA mice (B). Control assays were performed by redocking the
original cocrystallized epitopes to their respective H-2 haplotype
(PDB codes: 1vgk and 1zt7).
Table 4 Predicted interactions in MHC/peptide complexes related to cytokines production in murine lymp hnode cell
cultures
IL-10 IL-12 IFN-g IL-10 + IL-12 IL-10 + IFN-g
Specific MHC Interactions HB VWC HB VWC HB VWC HB VWC HB VWC
H-2K
d Exclusive tyr 7 cys 164 *NP *NP *NP phe 33 *NP *NP tyr 171 try 133 gly 149
Predominant try 73
tyr 159
*NP try 147 *NP gly 63 *NP *NP *NP tyr 156 *NP
H-2K
k Exclusive arg 155 H2O 373 *NP *NP gly 65 gly 69 phe 74 *NP *NP tyr 45 asp 152 *NP *NP
Predominant *NP *NP asp 156 asn 70 *NP *NP *NP *NP *NP *NP
Hydrogen bonds (HB) and Van der Waals contacts (VWC) were predicted by in silico Molecular Docking assays. Exclusive interactions (ExI) were predicted only
between the specified murine strain H-2K molecule and the peptides that induce the discriminated cytokine production in lymph node cell cultures.
Predominant interactions, despite not being exclusive, were predicted to occur at least twice more frequently for specific cytokine production-related peptides.
*NP - none predicted.
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selecting only peptides which were predicted by all algo-
rithms used (MHC-binding prediction and proteasomal
cleavage prediction algorithms), we simulated actual epi-
tope processing and, thus, selected only epitopes that had
a high possibility to exist during murine infection. Addi-
tionally, we performed in vitro assays with synthetic
versions of our selected epitopes, to test how accurate
in silico prediction would be in selecting epitopes with
immune effects during experimental infection.
We used a total lysate extract from the parasite (PLA),
as a specific positive control in our assays, since it contains
many potential antigens. This control induced blastogen-
esis in cell cultures from infected mice, apparently favoring
CD8+T cells proliferation and inducing the production of
cytokines related to multiple Th immune responses. Such
effects of PLA are compatible to what was observed pre-
viously for another parasites lysate extract [21] and may
account for the differences observed between infections
with L. (L.) amazonensis or L. (L.) major in mice: while a
mixed Th response profile can be observed in murine
infections by L. (L.) amazonensis, there is always a unique
and clearly defined Th response present in infections by
L. (L.) major (either Th1 or Th2, depending on the mouse
strain) [24,25].
Based on these observations, we performed assays
designed to understand if all potential epitopes (pep-
tides) derived from the COOH-extension of CPB would
induce a unique and well-characterized Th response or
if there would be peptides stimulating simultaneously
distinct Th responses. Our results indicated that the lat-
ter hypothesis is true. It is interesting to note that CD8+
T lymphocytes may also present profiles of cytokines
expression in a manner similar to CD4+ T lymphocytes
[26] and, so, may be the cell type responsible for the
production of the cytokines detected in the cell cultures.
B u tn o n eo ft h et e s t e dp e p t i d e sw a sa b l et oi n d u c eN O
production in cell cultures of BALB/c or CBA mice.
This diversity of stimuli by the tested peptides points
towards a possible survival strategy of the parasite: by
overloading the host immune system with multiple
immunomodulatory antigens, the parasite may induce it
to elicit a series of inefficient responses and, thus, ren-
der it unable to properly control the infection. These
inefficient responses would be translated as the mixed
Th response observed in murine infection by L. (L.)
amazonensis [24].
Contrary to what would be expected, the cells from
CBA mice in culture did not produced IFN-g when chal-
lenged with the synthetic epitopes. Although this fact
may seem contradictory at first, because the expression
of a Th1-related cytokine by a murine strain mildly resis-
tant to L. (L.) amazonensis infection seems logic, a pre-
vious review article by Alexander & Bryson (2005) [7]
already pointed out that, despite being useful to explain
some of the features that lead to disease control/exacer-
bation in Leishmania infections, the Th1/Th2 dichotomy
model is oversimplified. Thus, other factors, unrelated to
these responses, may influence the outcome of infection.
So, though we have tried to use the Th1/Th2 dichotomy
as a guideline along this study, it was not unexpected to
observe results that would not fit into the Th1/Th2
model, as the one indicated.
Also, in our study, we noted that stimulation for cyto-
kines production seems to be unrelated to stimulus for
proliferation. A possible explanation for this fact may be
an inhibition of IL-2 or its receptor production in lym-
phocytes by the parasites: such strategy would limit the
area of an immune response, allowing for dissemination
of the infection. Deficiencyt op r o d u c eI L - 2w a sp r e -
viously reported in patients with visceral leishmaniasis
[27], while in mice infected by L. (L.) amazonensis such
inhibition in the production of this cytokine was not
observed [28]. Further investigation of IL-2 production
and activity in the murine model of Leishmania infec-
tion is required to clarify this question.
In silico simulations of the interactions between MHC
and the predicted epitopes were also performed. These
simulations were helpful to indicate some major amino
acid residues of the MHC cleft that act on epitope bind-
ing. More importantly, they indicated some patterns of
MHC/epitope interaction that seem to be related to the
stimulus to produce a specific cytokine. Further studies
with increasing numbers of epitopes that stimulate spe-
cific cytokines in experimental murine infection with
Leishmania are required, but our results provide a pre-
view of a study methodology to understand immunomo-
dulatory effects of this parasite.
We were able to confirm, by the data gathered in this
study, the potential of the COOH-terminal extension
from L. (L.) amazonensis CPB to influence the outcome
of experimental murine infections by interfering,
through its derived peptides, with the balance of Th
cells, as we had previously proposed [21].
Taken in conjunction with our previous reports, our
present results shed light over another specific aspect of
the highly complex and fine-tuned network of interac-
tions that regulates the outcome of Leishmania infection
in mice. Also, we believe that, if applied to the study of
other potential immunoregulatory molecules from the
parasite, the methodological approach drafted here may
be very helpful for a fast definition of epitopes derived
from parasites proteins.
Conclusions
The proposed methodology for epitope mapping of
Leishmania proteins was shown to be very useful. Many
distinct predicted epitopes from the COOH-terminal
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Page 8 of 12extension from L. (L.) amazonesis CPB were able to pro-
mote the expression of distinct cytokines in murine cell
cultures, thus showing important immunomodulatory
properties of this extension.
The use of molecular docking technique to analyze
the interaction between peptides and MHC molecules in
the murine model of experimental Leishmania infection
showed evidences of a relation between the capacity of
peptides to induce the expression of specific cytokines
in the cell cultures and their interaction with key amino
acids residues in the MHC cleft.
Methods
Cultivation of parasites
L. (L.) amazonensis MHOM/BR/77/LTB0016 strain pro-
mastigotes (obtained from Coleção de Leishmania do
Instituto Oswaldo Cruz - CLIOC/IOC - Fiocruz) were
grown in Schneider’s medium (Sigma) supplemented with
10% fetal bovine serum (FBS - Gibco, Invitrogen, Brazil)
for 4 days at 28°C. For experimental infections, parasites
were washed 3× with 50 mM phosphate buffered saline
(PBS) (pH 7.2) centrifuged at 2,000 × g for 10 min at 4°C,
counted using a Neubauer chamber and suspended in PBS
at a concentration of 2 × 10
7 cells/mL.
Mice and experimental infection
Specific pathogen-free female 5-7 week old mice (strains
BALB/c and CBA) were obtained from the animal care
facility of Fiocruz (Centro de Criação de Animais de
Laboratório - CECAL/Fiocruz). For experimental infec-
tion, each animal was inoculated subcutaneously with 1.0
×1 0
6 log-phase promastigotes in PBS (50 μL) in the left
hindpaw. All procedures using animals were approved by
the Animal Ethics Committee of Fiocruz (Comissão de
Ética no Uso de Animais - CEUA/Fiocruz; L-0006/07).
Sequencing of L. (L.) amazonensis CP COOH-terminal
extension
DNA was extracted from 1.0 × 10
8 log-phase promasti-
gotes using the Wizard Genomic DNA purification kit
( P r o m e g a ,M a d i s o n ,W i s c o n s i n ,U S A ) .P C Rw a sp e r -
formed using specific sense and antisense primers for the
COOH-terminal extension of L. (L.) pifanoi CP Lpcys2 (5’-
GGATCCGCACCCAGACCCGTGATG-3’ and 5’-AAGC
TTCTACGTGTAGTGACAGGT-3’)[ 1 6 ]a n dt h eP C R
Core System (Promega). The PCR conditions were as fol-
lows: initial denaturation at 95°C for 1 min; 40 cycles of
denaturation at 95°C for 1 min, annealing at 60°C for
30 sec and extension at 72°C for 1 min; and a final exten-
sion cycle (72°C, 5 min). All PCR assays were performed
using an Eppendorf Mastercycler thermal cycler. The reac-
tion products were analyzed by agarose (1%) gel electro-
phoresis stained with ethidium bromide. The target band
was extracted using Wizard SV gel and PCR cleanup
system (Promega) and inserted into pGEM-t Easy vector
(Promega).
Escherichia coli competent cells were transformed by
thermal shock method and grown overnight at 37°C on
LB-agar plates supplemented with 100 μg/mL of ampicil-
lin, 40 μg/mL of isopropyl b-D-1-thiogalactopyranoside
and 40 μg/mL of 5-bromo-4-chloro-3-indolyl-beta-D-
galacto-pyranoside. Recombinant bacteria were grown in
liquid LB medium supplemented with 100 μg/mL ampicil-
lin. Plasmids were prepared using STET solution (8%
sacarose, 5% Tris-HCl pH 8.0, 50 μM EDTA pH 8.0, 5%
Triton X-100), purified with polyethylene glycol 8000 and
sequenced by PDTIS/Fiocruz DNA sequencing platform
(using a 3730 DNA Analyser - Applied Biosystems).
The results and quality of the sequencing were assessed
with BioEdit Sequence Alignment Editor Software and
the sequences submitted to NCBI Basic Local Alignment
Search Tool [BLAST] http://blast.ncbi.nlm.nih.gov/Blast.
cgi, to check for similar sequences.
T cell epitopes mapping strategy and peptide synthesis
Potential T cell epitopes derived from the COOH-terminal
extension were selected in silico, using the combination of
a T cell epitope binding algorithm (SYFPEITHI - http://
www.syfpeithi.de) with proteasome cleavage prediction
algorithms (NetChop- http://www.cbs.dtu.dk/services/
NetChop; PAProC - http://www.paproc.de). In this study
we considered only H2-K molecules for MHC-binding
prediction. The cutoff used for SYFPEITHI algorithm
results was a score value of 10, as it indicates the possibi-
lity of existence of at least one major anchor-amino acid at
the analyzed peptide sequence. Only the peptides present
in the intersection of the results from all used algorithms
were elected for the study. Such strategy was used aiming
to emulate more precisely the actual in vivo processing of
peptides that bind to MHC molecules. The elected pep-
tides were chemically synthesized by Creosalus (USA)
with 95% of purity (checked by HPLC) and predicted
MW-compatibility verified by ES-MS. Contamination of
the peptides with endotoxin was verified using Limulus
Amebocyte Lysate QCL-1000 kit (Lonza), according to
manufacturer’s instructions.
In vitro Lymphoproliferative assays in vitro
Lymphoproliferative assays were performed with cells
isolated from lesion draining lymph nodes of 15 mice
(BALB/c or CBA), 10 weeks post-infection with L. (L.)
amazonensis. After isolating and counting viable cells,
these were resuspended in RPMI medium supplemented
with 2% FBS and seeded into 96-wells flat bottom micro-
plates (5 × 10
5 cels/well). Positive proliferation controls
were carried out with concanavalin A (Con A - 2 μg/mL).
PLA was used as specific proliferation control. This anti-
gen was obtained by submitting L. (L.) amazonensis
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trifugation at 10,000 × g, 60 min and 4°C, after which the
pellet was discarded. Both PLA and the synthetic pep-
tides were assayed at a concentration of 30 μg/mL. The
cell culture microplates were kept for 3 days at 37°C in
an atmosphere of 5% CO2. In the final 16 h of incubation,
prior to the collection of the cells onto filter paper,
0.1 μCi of [
3H]-thymidine was added to each well. The
amount of radioactivity incorporated by the cells was
measured (in counts per minute - cpm) using scintilla-
tion liquid (toluene with 0.005% 1,4-bis(5-phenyloxazol-
2-yl)benzene and 0.6% 2,5-Diphenyloxazole) and a beta
scintillation counter (1600 CA, Packard Instrumental
Co., USA). Samples were run in triplicate in each assay
and at least three assays were performed for data analysis.
Phenotypic analysis of the T cells and cytokines and NO
production analysis
The phenotype of the peptide-responding cells from
L. (L.) amazonensis infected mice (BALB/c and CBA) was
determined using 2.5 × 10
6 lymph node cells/mL cul-
tured in 24-well flat-bottom plates (Nunc) under the
same conditions described above. The same positive and
specific proliferation controls were used. After 3 days in
culture, the supernatant was withdrawn and used in cyto-
kine and NO2
- experiments (see below), while the cells
were harvested, washed with PBS (500 × g,1 0m i n ,4 ° C )
and resuspended in PBS containing 0.05% sodium azide
and 2% FBS. Specific monoclonal antibodies PE-Cy5 Rat
A n t i - m o u s eC D 4a n dP ER a ta n t i - m o u s eC D 8 a( B D
Pharmigen, USA) were added [1:100] and the cell suspen-
sions were incubated for 30 min at 4°C. In the course of
cultivation, cell cultures were observed by light micro-
scopy to verify if their morphology presented any altera-
tion that could suggest stress or death of cells. Finally,
cells were washed with PBS (500 × g, 10 min, 4°C), resus-
pended at PBS with 1% paraformaldehyde and analyzed
using an EPICS ALTRA flow cytometer (Beckman Coul-
ter). For each sample, 10,000 lymphocytes were recorded
in list mode, and registered on a logarithmic scale histo-
gram. During data acquisition, the volume and inner
complexity parameters of events were controlled to
match those typical of murine lymphocytes. Analysis was
performed with the EXPO32™ (Applied Cytometry Sys-
tems - Beckman Coulter, USA) and Summit 4.3 (Dako,
USA) softwares.
The levels of cytokines (IL-12, IFN-g,IL-4 and IL-10) in
the supernatants of cell cultures obtained from immuno-
phenotyping assays were assessed with Quantikyne col-
orimetric sandwich ELISA kits (R&D systems), according
to manufacturer’s instructions. The thresholds for cyto-
kines detection indicated by the Quantikyne kits were:
IL-12p70 - 2.5 pg/mL, IFN-g -2p g / m L ,I L - 4-2p g / m L
and IL-10 - 4 pg/mL.
The nitrite (NO2
-) concentration was used as a mea-
sure of nitric oxide (NO) production in the same super-
natants using Griess reagent, as described previously
[29]. Briefly, 100 μL of the supernatants was added to
wells from 96-wells flat bottom plates and mixed with
100 μL of Griess reagent (2,5% phosphoric acid with 0.1%
naphthylene diamine 2 HCl and 1% sulphanilamide).
After incubation for 10 min at room temperature, absor-
bance for each well was defined at 540 nm. A standard
curve using sodium nitrite (0-200 μM) was used to assess
NO concentration in the supernatants. The threshold for
NO2
- detection using Griess reagent is down to 10
-9M.
Samples were run in triplicate at each assay and at
least three assays were performed for data analysis.
In silico assays (molecular docking)
For the docking simulations, we used murine class I MHC
molecules as receptors. The structural data for H-2K
d
(BALB/c) and H-2K
k (CBA) molecules were obtained
from Protein Data Bank (PDB - codes: 1vgk and 1zt7,
respectively). The H-2K
k molecule was co-crystallized
with Influenza virus peptide ligands (FEANGNLI), while
H-2k
d was obtained in complex with a synthetic peptide
(SYVNTNMGL).
The original ligands, present at each H-2 molecules in
their conformations retrieved from PDB file, were mutated
using the Swiss-PDB viewer software to match the selected
putative epitopes, keeping unchanged the crystallographic
conformations of their backbones.
The H-2/epitope file complexes, for docking assays,
were prepared using the GROMOS 96 force field [30]:
initial structures were optimized by minimizing potential
energy to adequate molecular crystallographic coordinates
to the force field. Partial atomic charges and the protona-
tion states were defined for each molecule, with the solva-
tion parameters of each atom set considering the amino
acids protonation state under pH 4.0 (zwitterionic state)
[31]. The putative ligands were set to a semi-flexible state,
where only side chain dihedral angles were allowed to
change, keeping the receptor rigid, using AutoTors soft-
ware [32]. Three highly conserved water molecules in the
H-2 active sites, which are known to play important roles
both in the maintenance of the active site structure and
ligand binding [33], were kept in the H-2 structures for
the docking assays.
The atomic cartesian coordinates of the crystallized H-
2 molecules (receptors) were then obtained after removal
of ligands from the in silico structure and, new files con-
taining this information, along with their atomic force
parameters (generated by the GROMOS 96 force field),
were created for docking analyses. The AutoDock 3.5
software was used to perform the molecular docking
assays. The grids matrix was calculated using a spacing of
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central atom of the ligand backbone as reference.
For each putative epitope, 8 docking simulations were
run each one generating 256 models of interaction,
summing up a total of 2048 models defined for each
epitope. These models were clustered in families using
as parameter the root mean square deviation (RMSD)
values between them: models were considered as mem-
bers of the same family if their RMSD value differed in
less than 3.5 Å. Families constituted of inadequate mod-
els, e.g. peptides interacting with the H-2 molecule out-
side its cleft, were dismissed.
Subsequently, the model presenting the best fit com-
pared to original crystalized molecules files, defined by
RMSD variance, was chosen for further analysis. In
cases were multiple models presented the same RMSD
variance values, the model with both the lower docked
energy value and lower intermolecular energy values
was selected.
The representative model of each family was assessed in
conjunction with its related H-2 active site structure to
identify the intermolecular interactions occurring: hydro-
gen bonds and Van der Waals contacts. The criteria to
define the existence of each type of atoms interactions
were: for hydrogen bonds - maximal distance of 2.5 Å
between hydrogen atom and acceptor atoms, and, for Van
der Waals contacts - maximal distance of 4.5 Å between
non-charged atoms. Only the residues of each H-2 mole-
cule that interacted at least 50% of the tested models were
considered as relevant and conserved.
Statistical analysis
Data from the in vitro assays were analyzed for statisti-
cal significance, using an unpaired Student’s t-test, and
considered significant when p < 0.05.
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